Yao Zhi Q, King Ellis, Prayther Deborah, Yin Deling, Moorman Jonathan
Department of Internal Medicine, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee 37614, USA.
Viral Immunol. 2007 Summer;20(2):276-87. doi: 10.1089/vim.2006.0096.
Reports have shown that a negative T cell costimulatory pathway mediated by PD-1 (programmed death-1) and PDL-1 (programmed death ligand-1) is associated with T cell exhaustion and persistent viral infection. Persistent hepatitis C virus (HCV) infection in humans is also characterized by impaired T lymphocyte function, but the role of the PD-1 and PDL-1 pathway in HCV infection is unknown. Here we report that T cells isolated from chronically HCV-infected patients express significantly higher levels of PD-1 when compared with healthy donors. In addition, PD-1 and PDL-1 expression is upregulated on healthy donor T cells exposed to HCV core, a nucleocapsid protein that is immunosuppressive; upregulation of PD-1 is mediated through interaction of HCV core with the complement receptor, gC1qR. Importantly, T cell functions that are dysregulated by HCV core, including T cell activation, proliferation, and apoptosis, can be restored by blocking PD-1 and PDL-1 engagement. Our results indicate that HCV core can upregulate a key negative T cell signaling pathway associated with viral persistence and highly expressed on the T cells of persistently infected individuals. This upregulation of the PD-1 and PDL-1 pathway in humans represents a novel and perhaps common mechanism by which a virus usurps host machinery to facilitate persistence.
报告显示,由程序性死亡受体1(PD-1)和程序性死亡配体1(PDL-1)介导的负性T细胞共刺激途径与T细胞耗竭及持续性病毒感染相关。人类慢性丙型肝炎病毒(HCV)感染也具有T淋巴细胞功能受损的特征,但PD-1和PDL-1途径在HCV感染中的作用尚不清楚。在此我们报告,与健康供者相比,从慢性HCV感染患者分离出的T细胞表达的PD-1水平显著更高。此外,在暴露于HCV核心蛋白(一种具有免疫抑制作用的核衣壳蛋白)的健康供者T细胞上,PD-1和PDL-1的表达上调;PD-1的上调是通过HCV核心蛋白与补体受体gC1qR的相互作用介导的。重要的是,通过阻断PD-1和PDL-1的结合,可以恢复被HCV核心蛋白失调的T细胞功能,包括T细胞活化、增殖和凋亡。我们的结果表明,HCV核心蛋白可上调与病毒持续性相关且在持续感染个体的T细胞上高表达的关键负性T细胞信号通路。人类中PD-1和PDL-1途径这种上调代表了一种新的、可能常见的机制,病毒借此利用宿主机制促进病毒持续性感染。